Cost‐minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B‐cell non‐Hodgkin's lymphoma in the U.K
Sweetenham, John, Hieke, Klaus, Kerrigan, Matthew, Howard, Paul, Smartt, Pamela F. M., McIntyre, Ann‐Marie, Townshend, Sarah
Published in British journal of haematology (01.07.1999)
Published in British journal of haematology (01.07.1999)
Get full text
Journal Article